Related Experiment Videos
CD40-CD154 interaction in experimental and human disease (review)
L Biancone1, V Cantaluppi, G Camussi
1Cattedra di Nefrologia, Dipartimento di Medicina Interna, Universita di Torino, 10126 Torino, Italy.
International Journal of Molecular Medicine
|March 23, 1999
Summary
The CD40-CD154 pathway is crucial for immune responses and lymphocyte activation. Disrupting this interaction shows therapeutic potential in autoimmune diseases, infections, cancer, and transplant rejection.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Cell-to-cell signals between T lymphocytes and antigen-presenting cells are critical for immune response regulation.
- The CD40-ligand (CD154) receptor-ligand pair is essential for lymphocyte activation.
- Mutations in the CD154 gene cause severe human immunodeficiency, highlighting its importance.
Purpose of the Study:
- To review the functional characterization of the CD40-CD154 system.
- To explore therapeutic strategies targeting the CD40-CD154 interaction.
- To summarize advances in understanding CD40 and CD154 roles in various diseases.
Main Methods:
- Literature review of studies on CD40-CD154.
- Analysis of experimental models and human disease data.
- Focus on molecular regulatory events and therapeutic applications.
Main Results:
- Disruption of CD40-CD154 interaction is effective in treating experimental autoimmune diseases and transplant rejection.
- Abnormalities in the CD40-CD154 pathway are implicated in various human immune-mediated diseases.
- CD40 and CD154 play roles in immunity against pathogens, cancer development, and atherogenesis.
Conclusions:
- The CD40-CD154 pathway is a significant target for therapeutic intervention in diverse diseases.
- Understanding CD40-CD154 molecular regulation is key to developing novel treatments.
- This pathway's involvement spans autoimmune disorders, infectious diseases, cancer, and cardiovascular conditions.